Evaluation of total IGF-I assay methods using samples from Type I and Type II diabetic patients

Journal of Immunological Methods

Volumn 259, Issue 1-2, 2002, Pages 11-24

  Chestnut, Regina E ^a   Quarmby, Valerie ^a  

^a GENENTECH INC   (United States)

Author keywords

AEE; ASEC; Displacement assays; IGF I; IGFBPs; Type I and Type II diabetics

Indexed keywords

BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ACCURACY; ANALYTIC METHOD; ARTICLE; BLOOD DONOR; CHROMATOGRAPHY; CONTROLLED STUDY; EXTRACTION; HUMAN; IMMUNOASSAY; INSULIN DEPENDENT DIABETES MELLITUS; MEDICAL ASSESSMENT; MEDICAL LITERATURE; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; SAMPLING; STANDARDIZATION;

ADULT; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; EVALUATION STUDIES; HUMANS; IMMUNOASSAY; INSULIN-LIKE GROWTH FACTOR I; REFERENCE STANDARDS;

EID: 0036133123     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(01)00478-1     Document Type: Article

References (28)

1. Urinary growth hormone excretion in post menarcheal adolescent girls with type I diabetes
2. Effect of diabetes and its control on insulin-like growth factors in the young subject with type I diabetes
3. Insulin-like growth factors and diabetes
4. Increased proteolysis of insulin-like growth factor-binding protein-3 (IGFBP-3) in noninsulin-dependent diabetes mellitus serum, with elevation of a 29-kilodalton (kDa) glycosylated IGFBP-3 fragment contained in the approximately 130- to 150-kDa ternary complex
5. Radioimmunoassays for IGFs and IGFBPs
6. Serum levels of insulin-like growth factor I and insulin-like growth factor-binding protein-3 in children with insulin-dependent diabetes mellitus
7. Relationship between non-enzymatic glycosylation and changes in serum insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 levels in patients with type 2 diabetes mellitus
8. Is insulin-like growth factor I associated with diabetic retinopathy?
9. Association of elevated IGF-I levels with increased retinopathy in late-onset diabetes
10. Circulating levels of free insulin-like growth factors in obese subjects: The impact of type 2 diabetes
11. A comparative analysis of methods to measure insulin-like growth factor-I in human serum
12. Correlation study of measurement of human IGFBP3 using two RIAs and an ELISA
13. Progression of diabetic retinopathy and changes in serum insulin-like growth factor I (IGF-I) during continuous subcutaneous insulin infusion (CSII)
14. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in type I and type II diabetes mellitus patients
15. Von Willebrand factor (VIII R:Ag), fibronectin and insulin-like growth factors I and II in diabetic retinopathy and nephropathy
16. Effects of recombinant human IGF-I on total and free IGF-I concentrations, IGF-binding proteins and glycemic response in humans
17. Serum levels of growth hormone-binding protein and insulin-like growth factor I in children and adolescents with type I insulin-dependent diabetes mellitus
18. Insulin-like growth factors: Studies in diabetics with and without retinopathy
19. Insulin-like growth factor I, its binding proteins 1 and 3, and growth hormone-binding protein in children and adolescents with insulin-dependent diabetes mellitus: Clinical implications
20. Serum somatomedin levels in adults with chronic renal failure: The importance of measuring IGF-I and IGF-II in acid-chromatographed uremic serum
21. How much insulin-like growth factor I (IGF-I) circulates? Impact of standardization on IGF-I assay accuracy
22. Serum levels of insulin-like growth factor (IGF) and IGF-binding protein in insulin-dependent diabetics during an episode of severe metabolic decompensation and the recovery phase
23. 1 in type I diabetes
24. Insulin-infusion pump treatment of diabetes: Influence of improved metabolic control on plasma somatomedin levels
25. Serum insulin-like growth factor I levels in adult diabetic patients: The effect of age
26. Somatomedin-C/IGF-I measured by radioimmunoassay and somatomedin bioactivity in adolescents with insulin dependent diabetes compared with puberty matched controls